EPFL Innovation Park
34 articles with Sophia Genetics
SOPHiA GENETICS, leader in Data-Driven Medicine, announced that Bram Goorden joined its Executive team, holding the dual role of Chief Commercial Officer and Head of North America.
Supporting the Company's Global Expansion to Meet Growing Clinical and Biopharma Demand for Data-Driven Medicine - SOPHiA GENETICS enters next stage of its global expansion with oversubscribed Series F round exceeding $110 million, led by major health-tech fund and followed by strategic industry leader - Company demonstrates solidity of its business model with banks joining in the round - Didier Hirsch, former CFO at Agilent, joins the company's Board of Directors a
SOPHiA GENETICS, leader in Data-Driven Medicine, launches a first-of-its-kind multimodal solution to predict COVID-19 disease evolution, opening new dimensions of insight into the fight against the worldwide pandemic.
5/21/2020Biopharma and life sciences companies from across the globe provide updates on their pipelines and business operations.
4/10/2020Biopharma companies strengthen their leadership teams and boards with this week's Movers & Shakers.
A summary of daily biopharma industry news. Please check out stories that are trending on March 26, 2020.
2/21/2020Biopharma and life sciences companies strengthen their leadership teams and board with this week's Movers & Shakers.
LAUSANNE , Switzerland and BOSTON , Feb. 20, 2020 /PRNewswire/ -- SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that former Foundation Medicine CEO Troy Cox has been elected as Chairman of the Board of Directors, effective March 1, 2020 . He is replacing Antoine Duchateau , who has served as chairman since 2013 and will continue as a board member. Cox j
2/14/2020Biopharma and life sciences companies bolster their leadership teams and board with this week's Movers & Shakers.
Feb. 13, 2020 18:00 UTC LAUSANNE, Switzerland & BOSTON--( BUSINESS WIRE )-- SOPHiA GENETICS, leader in Data-Driven Medicine, announced today the appointment of Philippe Menu, MD-PhD, MBA, as Chief Medical Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200213005647/en/ Dr. Philippe Menu joins SOPHiA GENETICS (Photo: SOPHiA GENETICS) Dr. Philippe Menu brings a unique blend of medical expertise acr
While the conditions surrounding the City by the Bay are in a negative light, there is still a significant amount of positive news coming out of the conference.
Mr. Silva-Craig brings over 25 years of experience holding executive positions in healthcare.
SOPHiA GENETICS, leader in Data-Driven Medicine, announced today at the American Society of Human Genetics Annual Meeting (ASHG) the release of the new version of SOPHiA Whole Exome Solution.
ADC Therapeutics and SOPHiA GENETICS Partner for Biomarker Discovery in Pivotal Phase II Clinical Trial
Study to identify genomic markers associated with clinical response to ADCT-402 (loncastuximab tesirine) in relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
7/3/2019Biotech and pharma companies strengthen their executive leadership and board positions.
SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that Troy Cox joined its Board of Directors, effective immediately. Mr. Cox, who previously held the position of Chief Executive Officer of Foundation Medicine, brings extensive knowledge of the biopharmaceutical industry to SOPHiA GENETICS.
SOPHiA GENETICS Achieves CE-IVD Milestone for Its Solid Tumor Solution for Accurate Cancer Detection
SOPHiA GENETICS, global leader in Data-Driven Medicine, announced the CE-IVD marking of its Solid Tumor Solution, a new step in the fight against cancer.
SOPHiA GENETICS, a leading health tech company, announced today the closing of a $77 million investment round to accelerate the democratization of Data-Driven Medicine.
Paragon Genomics Partners Its Ultra-High Multiplexed Target Enrichment Technology With SOPHiA GENETICS For Comprehensive Genomic Solutions
Universal SOPHiA AI Platform Now Includes Paragon Genomics' Accurate and Sensitive CleanPlex® NGS Target Enrichment Technology for Its Rapidly-Growing Global Community of Cancer Centers
SOPHiA GENETICS Presents Alamut Genova, the Latest Evolution of the Alamut Software for Genomic Variant Exploration
SOPHiA GENETICS, leader in Data-Driven Medicine, has announced today from the annual meeting of the American Society of Human Genetics (ASHG), the release of Alamut Genova, the advanced variant exploration software for genomic data visualization and interpretation.